Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Apr;11(4):645–650. doi: 10.1128/aac.11.4.645

Therapy of Antimicrobial-Resistant Typhoid Fever

Thomas Butler *, Nguyen Ngoc Linh †,‡,§,1, Keith Arnold †,‡,§, Michael D Adickman †,‡,§, Duong Minh Chau †,‡,§, Mach Muoi Muoi †,‡,§
PMCID: PMC352043  PMID: 324398

Abstract

Antimicrobial-resistant typhoid fever in Saigon was studied by examining in vitro antimicrobial susceptibilities of Salmonella typhi strains and conducting a randomized clinical trial of ampicillin and trimethoprim-sulfamethoxazole (TMP-SMZ). Isolates of S. typhi were obtained from blood or stool cultures of 90 patients. Of 87 isolates tested for antimicrobial susceptibility, 65 (75%) were resistant (R) to chloramphenicol, streptomycin, sulfonamide, and tetracycline, and 22 (25%) were susceptible (S). The drug resistance was transferable to Escherichia coli and was found in 11 different Vi-phage types. All isolates were susceptible to ampicillin and to TMP-SMZ. Agar dilution studies of TMP and SMZ showed synergistic inhibition of growth in all 18 S isolates and in 12 of 48 R isolates tested. The clinical trial of ampicillin and TMP-SMZ showed that both drugs were equally effective. Treatment failure with both drugs was more frequent in patients with S isolates than in patients with R isolates. Therefore, in an area where antimicrobial-resistant typhoid fever exists, patients with R isolates should receive either ampicillin or TMP-SMZ, but patients with S isolates should be treated with chloramphenicol.

Full text

PDF
647

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akinkugbe O. O., Lewis E. A., Montefiore D., Okubadejo O. A. Trimethoprim and sulphamethoxazole in typhoid. Br Med J. 1968 Sep 21;3(5620):721–722. doi: 10.1136/bmj.3.5620.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson E. S., Smith H. R. Chloramphenicol resistance in the typhoid bacillus. Br Med J. 1972 Aug 5;3(5822):329–331. doi: 10.1136/bmj.3.5822.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anderson E. S. The problem and implications of chloramphenicol resistance in the typhoid bacillus. J Hyg (Lond) 1975 Apr;74(2):289–299. doi: 10.1017/s0022172400024360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anderson K. E., Joseph S. W., Nasution R., Sunoto, Butler T., Van Peenen P. F., Irving G. S., Saroso J. S., Watten R. H. Febrile illnesses resulting in hospital admission: a bacteriological and serological study in Jakarta, Indonesia. Am J Trop Med Hyg. 1976 Jan;25(1):116–121. doi: 10.4269/ajtmh.1976.25.116. [DOI] [PubMed] [Google Scholar]
  5. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  6. Brown J. D., Duong Hong M. o., Rhoades E. R. Chloramphenicol-resistant Salmonella typhi in Saigon. JAMA. 1975 Jan 13;231(2):162–166. [PubMed] [Google Scholar]
  7. Butler T., Linh N. N., Arnold K., Pollack M. Chloramphenicol-resistant typhoid fever in Vietnam associated with R factor. Lancet. 1973 Nov 3;302(7836):983–985. doi: 10.1016/s0140-6736(73)91086-6. [DOI] [PubMed] [Google Scholar]
  8. Calderon E. Amoxicillin in the treatment of typhoid fever due to chloramphenicol-resistance Salmonella typhi. J Infect Dis. 1974 Jun;129(0):suppl–suppl:S221. doi: 10.1093/infdis/129.supplement_2.s219. [DOI] [PubMed] [Google Scholar]
  9. Cardoso N. Double-blind trial with chloramphenicol and the combination trimethoprim-sulfamethoxazole in typhoid. S Afr Med J. 1972 Sep 9;46(36):1286–1287. [PubMed] [Google Scholar]
  10. Geddes A. M., Fothergill R., Goodall J. A., Dorken P. R. Evaluation of trimethoprim-sulphamethoxazole compound in treatment of salmonella infections. Br Med J. 1971 Aug;3(5772):451–454. doi: 10.1136/bmj.3.5772.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gilman R. H., Terminel M., Levine M. M., Hernandez-Mendosa P., Calderone E., Vasquez V., Martinez E., Snyder M. J., Hornick R. B. Comparison of trimethoprim-sulfamethoxazole and amoxicillin in therapy of chloramphenicol-resistant and chloramphenicol-sensitive typhoid fever. J Infect Dis. 1975 Dec;132(6):630–636. doi: 10.1093/infdis/132.6.630. [DOI] [PubMed] [Google Scholar]
  12. Grindley N. D., Humphreys G. O., Anderson E. S. Molecular studies of R factor compatibility groups. J Bacteriol. 1973 Jul;115(1):387–398. doi: 10.1128/jb.115.1.387-398.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hassan A., Hathout S., Safwat Y., Erian M., Wahab M. F., Sorensen K., Sippel J., Farid Z. A comparative evaluation of the treatment of typhoid fevers with co-trimoxazole and chloramphenicol in Egypt. J Trop Med Hyg. 1975 Mar;78(3):50–53. [PubMed] [Google Scholar]
  14. Kamat S. A. Evaluation of therapeutic efficacy of trimethoprim-sulphamethoxazole and chloramphenicol in enteric fever. Br Med J. 1970 Aug 8;3(5718):320–322. doi: 10.1136/bmj.3.5718.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kaye D., Eyckmans L., Rocha H., Prata A., Hook E. W. Comparison of parenteral ampicillin and parenteral chloramphenicol in the treatment of typhoid fever. Ann N Y Acad Sci. 1967 Sep 27;145(2):423–428. doi: 10.1111/j.1749-6632.1967.tb50241.x. [DOI] [PubMed] [Google Scholar]
  16. Lampe R. M., Mansuwan P., Duangmani C. Letter: Chloramphenicol--resistant typhoid. Lancet. 1974 Apr 6;1(7858):623–624. doi: 10.1016/s0140-6736(74)92678-6. [DOI] [PubMed] [Google Scholar]
  17. Lawrence R. M., Goldstein E., Hoeprich P. D. Typhoid fever caused by chloramphenicol-resistant organisms. JAMA. 1973 May 7;224(6):861–863. [PubMed] [Google Scholar]
  18. Nguyen Ngoc Linh Letter: Typhoid fever treated with chloramphenicol and co-trimoxazole. Lancet. 1974 Jun 15;1(7868):1222–1222. doi: 10.1016/s0140-6736(74)91025-3. [DOI] [PubMed] [Google Scholar]
  19. Overturf G., Marton K. I., Mathies A. W., Jr Antibiotic resistance in typhoid fever. Chloramphenicol resistance among clinical isolates of Salmonella typhosa in Los Angeles, 1972--epidemiologic and bacteriologic characteristics. N Engl J Med. 1973 Aug 30;289(9):463–465. doi: 10.1056/NEJM197308302890906. [DOI] [PubMed] [Google Scholar]
  20. Pillay N., Adams E. B., North-Coombes D. Comparative trial of amoxycillin and chloramphenicol in treatment of typhoid fever in adults. Lancet. 1975 Aug 23;2(7930):333–334. doi: 10.1016/s0140-6736(75)92776-2. [DOI] [PubMed] [Google Scholar]
  21. Robertson R. P., Wahab M. F., Raasch F. O. Evaluation of chloramphenicol and ampicillin in salmonella enteric fever. N Engl J Med. 1968 Jan 25;278(4):171–176. doi: 10.1056/NEJM196801252780401. [DOI] [PubMed] [Google Scholar]
  22. Sanford J. P., Linh N. N., Kutscher E., Arnold K., Gould K. Oxolinic acid in the treatment of typhoid fever due to chloramphenicol-resistant strains of Salmonella typhi. Antimicrob Agents Chemother. 1976 Mar;9(3):387–392. doi: 10.1128/aac.9.3.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sardesai H. V., Karandikar R. S., Harshe R. G. Comparative trial of Co-trimoxazole and Chloramphenicol in Typhoid Fever. Br Med J. 1973 Jan 13;1(5845):82–83. doi: 10.1136/bmj.1.5845.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Scragg J. N., Rubidge C. J. Amoxycillin in the treatment of typhoid fever in children. Am J Trop Med Hyg. 1975 Sep;24(5):860–865. doi: 10.4269/ajtmh.1975.24.860. [DOI] [PubMed] [Google Scholar]
  25. Scragg J. N., Rubidge C. J. Trimethoprim and sulphamethoxazole in typhoid fever in children. Br Med J. 1971 Sep 25;3(5777):738–741. doi: 10.1136/bmj.3.5777.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Thorne G. M., Farrar W. E., Jr Superinfection compatibility of R factors in Shigella dysenteriae type 1 from Central America and Salmonella typhi from Mexico. J Infect Dis. 1974 Sep;130(3):284–287. doi: 10.1093/infdis/130.3.284. [DOI] [PubMed] [Google Scholar]
  27. Uwaydah M. Cefazolin in the treatment of acute enteric fever. Antimicrob Agents Chemother. 1976 Jul;10(1):52–56. doi: 10.1128/aac.10.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Uwaydah M., Matossian R., Balabanian M. Co-trimoxazole compared to chloramphenicol in the treatment of enteric fever. Scand J Infect Dis. 1975;7(2):123–126. doi: 10.3109/inf.1975.7.issue-2.08. [DOI] [PubMed] [Google Scholar]
  29. Vázquez V., Calderón E., Rodríquez R. S. Chloramphenicol-resistant strains of Salmonella typhosa. N Engl J Med. 1972 Jun 1;286(22):1220–1220. [PubMed] [Google Scholar]
  30. WOODWARD T. E., SMADEL J. E. MANAGEMENT OF TYPHOID FEVER AND ITS COMPLICATIONS. Ann Intern Med. 1964 Jan;60:144–157. doi: 10.7326/0003-4819-60-1-144. [DOI] [PubMed] [Google Scholar]
  31. Weissman J. B., Rice P. A., Krogstad D. J., Baine W. B., Gangarosa E. J. Risk of severe intestinal infection to the traveler in Mexico. J Infect Dis. 1973 Oct;128(4):574–577. doi: 10.1093/infdis/128.4.574. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES